Literature DB >> 29471568

The Receptor Interacting Protein Kinases in the Liver.

Lily Dara1,2.   

Abstract

The receptor interacting serine/threonine kinase1 and 3 (RIPK1, RIPK3) are regulators of cell death and survival. RIPK1 kinase activity is required for necroptosis and apoptosis, while its scaffolding function is necessary for survival. Although both proteins can mediate apoptosis, RIPK1 and RIPK3 are most well-known for their role in the execution of necroptosis via the mixed lineage domain like pseudokinase. Necroptosis is a caspase-independent regulated cell death program which was first described in cultured cells with unknown physiologic relevance in the liver. Many recent reports have suggested that RIPK1 and/or RIPK3 participate in liver disease pathogenesis and cell death. Notably, both proteins have been shown to mediate inflammation independent of cell death. Whether necroptosis occurs in hepatocytes, and how it is executed in the presence of an intact caspase machinery is controversial. In spite of this controversy, it is evident that RIPK1 and RIPK3 participate in many experimental liver disease models. Therefore, in addition to cell death signaling, their necroptosis-independent role warrants further examination. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29471568      PMCID: PMC5864113          DOI: 10.1055/s-0038-1629924

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  126 in total

1.  RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein.

Authors:  Akhil Rajput; Andrew Kovalenko; Konstantin Bogdanov; Seung-Hoon Yang; Tae-Bong Kang; Jin-Chul Kim; Jianfang Du; David Wallach
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

2.  RIP3, a novel apoptosis-inducing kinase.

Authors:  X Sun; J Lee; T Navas; D T Baldwin; T A Stewart; V M Dixit
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

3.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

4.  Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.

Authors:  Marta B Afonso; Pedro M Rodrigues; Tânia Carvalho; Marta Caridade; Paula Borralho; Helena Cortez-Pinto; Rui E Castro; Cecília M P Rodrigues
Journal:  Clin Sci (Lond)       Date:  2015-06-15       Impact factor: 6.124

5.  Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

Authors:  Kim Newton; Debra L Dugger; Katherine E Wickliffe; Neeraj Kapoor; M Cristina de Almagro; Domagoj Vucic; Laszlo Komuves; Ronald E Ferrando; Dorothy M French; Joshua Webster; Merone Roose-Girma; Søren Warming; Vishva M Dixit
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

6.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition.

Authors:  William J Kaiser; Lisa P Daley-Bauer; Roshan J Thapa; Pratyusha Mandal; Scott B Berger; Chunzi Huang; Aarthi Sundararajan; Hongyan Guo; Linda Roback; Samuel H Speck; John Bertin; Peter J Gough; Siddharth Balachandran; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

Review 7.  Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond.

Authors:  Jae Ryul Bae; Byoung Dae Lee
Journal:  BMB Rep       Date:  2015-05       Impact factor: 4.778

8.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

Review 9.  Questions and controversies: the role of necroptosis in liver disease.

Authors:  Lily Dara; Zhang-Xu Liu; Neil Kaplowitz
Journal:  Cell Death Discov       Date:  2016-12-05

10.  Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.

Authors:  Jiefei Geng; Yasushi Ito; Linyu Shi; Palak Amin; Jiachen Chu; Amanda Tomie Ouchida; Adnan Kasim Mookhtiar; Heng Zhao; Daichao Xu; Bing Shan; Ayaz Najafov; Guangping Gao; Shizuo Akira; Junying Yuan
Journal:  Nat Commun       Date:  2017-08-25       Impact factor: 14.919

View more
  15 in total

1.  MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.

Authors:  Tianpeng Zhang; Junjie Hu; Xiaomei Wang; Xiaoling Zhao; Zhuoyu Li; Junqi Niu; Clifford J Steer; Guohua Zheng; Guisheng Song
Journal:  J Hepatol       Date:  2018-09-13       Impact factor: 25.083

2.  Acetaminophen Hepatotoxicity.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Semin Liver Dis       Date:  2019-03-08       Impact factor: 6.115

Review 3.  Roles of RIPK3 in necroptosis, cell signaling, and disease.

Authors:  Michael J Morgan; You-Sun Kim
Journal:  Exp Mol Med       Date:  2022-10-12       Impact factor: 12.153

4.  Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome.

Authors:  Liwen Chen; Zhujun Cao; Lei Yan; Yezhou Ding; Xinghua Shen; Kehui Liu; Xiaogang Xiang; Qing Xie; Chuanwu Zhu; Shisan Bao; Hui Wang
Journal:  Front Physiol       Date:  2020-06-16       Impact factor: 4.566

Review 5.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

6.  MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.

Authors:  Xiaoqin Wu; Kyle L Poulsen; Carlos Sanz-Garcia; Emily Huang; Megan R McMullen; Sanjoy Roychowdhury; Srinivasan Dasarathy; Laura E Nagy
Journal:  J Hepatol       Date:  2020-03-24       Impact factor: 25.083

Review 7.  Necroptotic Cell Death in Liver Transplantation and Underlying Diseases: Mechanisms and Clinical Perspective.

Authors:  Shaojun Shi; Monique M A Verstegen; Laura Mezzanotte; Jeroen de Jonge; Clemens W G M Löwik; Luc J W van der Laan
Journal:  Liver Transpl       Date:  2019-07       Impact factor: 5.799

Review 8.  Cell Death in Liver Diseases: A Review.

Authors:  Layla Shojaie; Andrea Iorga; Lily Dara
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

9.  The Role of RIPK1/3 in Adult Onset Still's Disease Patients With Liver Damage: A Preliminary Study.

Authors:  Xuesong Liu; Ruru Guo; Xinyu Meng; Jianchen Fang; Liangjing Lu
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

Review 10.  Immunological mechanisms and therapeutic targets of fatty liver diseases.

Authors:  Hua Wang; Wajahat Mehal; Laura E Nagy; Yaron Rotman
Journal:  Cell Mol Immunol       Date:  2020-12-02       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.